You are here: Industry Insights > OTC

News List

Industry urges government to define, implement OTC regulations on priority expresspharma
September 16, 2020
A draft report of OTC Drug regulations and the proposed OTC drug list have been submitted to the Drugs Consultative Committee (DCC).
Shilpa Medicare forays into the OTC segment expresspharma
August 25, 2020
Shilpa Medicare ventured into the OTC segment with the launch of ‘ready-to-drink’ green tea films. The company is marketing it as an immunity booster as well.
OTC healthcare products: A growth area for India Pharma Inc expresspharma
August 10, 2020
Dr Atish Rodge, MD & Founder, Allmpus Laboratories points out that India is an increase in demand for OTC healthcare products and informs that increasing health expenditure due to the pandemic, a sudden rise in lifestyle diseases, and massive ...
Dr Reddy’s Laboratories launch OTC Nicotine Polacrilex Lozenges in the US expresspharma
July 15, 2020
Dr Reddy’s Laboratories announced the launch of over-the-counter (OTC) Nicotine Polacrilex Lozenges, 2 mg and 4 mg, the store brand version of Nicorette lozenges in the US market.
Govt to announce regulatory guidelines for OTC drugs: Dy Drug Controller, MoH&FW expresspharma
June 28, 2020
The consultative committee will give its recommendations to the DTAB, which will be submitted to the government to amend the rules of OTC regulations.
Takeda to sell assets in Asia Pacific to Celltrion for $266m pharmaceutical-technology
June 15, 2020
Takeda Pharmaceutical has signed an agreement to sell certain non-core over-the-counter (OTC) and prescription pharmaceutical assets available only in the Asia Pacific to South Korean biopharmaceutical firm Celltrion for $266m in an upfront payment.
Takeda offloads $670M of European drugs as consumer health sale rumors resurface fiercepharma
April 26, 2020
Takeda has inked yet another deal aimed at lowering its debt level after the Shire acquisition.The Japanese pharma said Friday that is has agreed to sell about 110 over-the-counter and prescription drugs in Europe, as well as two manufacturing sites, to D
Takeda to sell OTC and non-core assets to Orifarm for $670m pharmaceutical-technology
April 26, 2020
Takeda Pharmaceutical has signed an agreement to sell around 110 of its non-core over-the-counter (OTC) and prescription pharmaceutical products to Danish pharmaceutical firm Orifarm Group for $670m.
Legacy Pharmaceutical Packaging Expands contractpharma
April 15, 2020
Purchases three high speed blistering and cartoning lines with serialization and aggregation capabilities.
Voltaren approved for arthritis pain over-the-counter in the US europeanpharmaceuticalreview
March 11, 2020
Voltaren Arthritis Pain has been approved by the FDA as an over-the-counter product for the temporary relief of arthritis pain.

Previous page 1 2 3 4 5 6 Next page